Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Fumihiko Kanai"'
Autor:
Kenichiro Okimoto, Sadahisa Ogasawara, Tetsuhiro Chiba, Fumihiko Kanai, Hajime Yokota, Tenyu Motoyama, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Yasuo Iwadate, Naokatsu Saeki, Osamu Yokosuka
Publikováno v:
Case Reports in Gastroenterology, Vol 7, Iss 1, Pp 182-187 (2013)
Intracranial metastasis of hepatocellular carcinoma (HCC) is rare, but has an extremely poor prognosis. We report a case with successful surgical removal of intracranial metastasis of HCC. A 32-year-old man was admitted to our hospital with severe vo
Externí odkaz:
https://doaj.org/article/4426a78fbf234865b2be4f283b52174d
Autor:
Yuki Haga, Tetsuhiro Chiba, Gaku Ohira, Fumihiko Kanai, Hajime Yokota, Tenyu Motoyama, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Hideaki Miyauchi, Hisahiro Matubara, Osamu Yokosuka
Publikováno v:
Case Reports in Gastroenterology, Vol 7, Iss 1, Pp 37-43 (2013)
A 75-year-old woman with abdominal pain and vomiting was admitted to our hospital. Colonoscopy showed an advanced colon cancer that encompassed the entire circumference of the descending colon’s lumen. The patient was diagnosed with occlusive ileus
Externí odkaz:
https://doaj.org/article/a4e2b0184e91405e8d0b81d9f18994b1
Autor:
Sadahisa Ogasawara, Tetsuhiro Chiba, Tenyu Motoyama, Naoya Kanogawa, Tomoko Saito, Yusuke Shinozaki, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Hideyuki Kato, Shinichiro Okabe, Fumihiko Kanai, Masaharu Yoshikawa, Osamu Yokosuka
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163119 (2016)
Hypovascular nodules often occur together with hypervascular hepatocellular carcinoma (HCC). However, it remains controversial whether hypovascular nodules associated with hypervascular HCC have any prognostic value. This study evaluated the prognost
Externí odkaz:
https://doaj.org/article/509c45b900584b798d55c8473417d91a
Autor:
Ryota Masuzaki, Ryosuke Tateishi, Haruhiko Yoshida, Eriko Goto, Takahisa Sato, Takamasa Ohki, Tadashi Goto, Hideo Yoshida, Fumihiko Kanai, Yosuke Sugioka, Hitoshi Ikeda, Shuichiro Shiina, Takao Kawabe, Masao Omata
Publikováno v:
Canadian Journal of Gastroenterology, Vol 22, Iss 9, Pp 753-757 (2008)
BACKGROUND: Liver stiffness measurement (LSM) by transient elastography has recently been validated for the evaluation of liver fibrosis in chronic liver diseases. The present study focused on cases in which liver biopsy and LSM were discordant.
Externí odkaz:
https://doaj.org/article/3d060ec8bfab402a812ad24cdc6f98e5
Autor:
Tomoko Saito, Tetsuhiro Chiba, Kaori Yuki, Yoh Zen, Motohiko Oshima, Shuhei Koide, Tenyu Motoyama, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Motohisa Tada, Fumihiko Kanai, Yuichi Takiguchi, Atsushi Iwama, Osamu Yokosuka
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e70010 (2013)
Metformin has been widely used as an oral drug for diabetes mellitus for approximately 60 years. Interestingly, recent reports showed that metformin exhibited an anti-tumor action in a wide range of malignancies including hepatocellular carcinoma (HC
Externí odkaz:
https://doaj.org/article/54990a8bb58b41c4957233e8bfef6ccf
Autor:
Shuntaro Obi, Morito Monden, Fumihiko Kanai, Shuichi Kaneko, Kazuhide Yamamoto, Hideji Nakamura, Akihito Tsuji, Takeharu Yamanaka, Koichi Hirata, Yoshito Tomimaru, Masao Omata, M. Tanaka, Etsuro Hatano, Hiroaki Nagano, Toshiyuki Itamoto, Shinsuke Kojima, Shoji Kubo
Publikováno v:
Hepatology Research. 48:717-726
Aim No effective therapies for extrahepatic metastases from hepatocellular carcinoma (HCC) have yet been identified. Previous studies suggested a potentially promising antitumor effect of combination therapy of S-1, a novel oral dihydropyrimidine deh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9130d0c8f94c9d5f52e4d45eebf2dcd1
https://doi.org/10.1111/hepr.13067
https://doi.org/10.1111/hepr.13067
Autor:
Akinobu Tawada, Hideki Hanaoka, Osamu Yokosuka, Kazue Nagai, Tetsuhiro Chiba, Takeshi Sugawara, Yoshihiko Ooka, Tenyu Motoyama, Sadahisa Ogasawara, Naoya Kanogawa, Tomoo Nakagawa, Eiichiro Suzuki, Fumihiko Kanai
Publikováno v:
Hepatology. 67:575-585
This randomized, double-blind, placebo-controlled trial evaluated dexamethasone efficacy at preventing fever, anorexia, and nausea/vomiting, the most frequent adverse events of transcatheter arterial chemoembolization (TACE) in patients with hepatoce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093a61414ba5b39c17c408f0a46d0475
https://doi.org/10.1002/hep.29403
https://doi.org/10.1002/hep.29403
Autor:
Takashi Kumada, Yasutaka Chiba, Yutaka Sasaki, Kazuhide Yamamoto, Keisuke Hino, Chikara Ogawa, Masatoshi Kudo, Yasuharu Imai, Takuji Okusaka, Namiki Izumi, Kazuomi Ueshima, Shouta Iwadou, Fumihiko Kanai, Sadahisa Ogasawara, Hiroaki Nagano, Yasuaki Arai, Hiroshi Aikata, Shuntaro Obi, Etsuro Hatano
Publikováno v:
Liver Cancer
Objective: In SILIUS (NCT01214343), combination of sorafenib and hepatic arterial infusion chemotherapy did not significantly improve overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) compared with sorafenib alone. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28b102faaaa6ee8fc87ed621860f5da1
https://pubmed.ncbi.nlm.nih.gov/31799207
https://pubmed.ncbi.nlm.nih.gov/31799207
Autor:
N Izumi, Hatano E, Keisuke Hino, Shuntaro Obi, Shouta Iwadou, Nagano H, Ogawa C, K. Ueshima, Yutaka Sasaki, Hiroshi Aikata, Fumihiko Kanai, Y. Arai, Sadahisa Ogasawara, Takuji Okusaka, Ken Yamamoto, Imai Y, Masatoshi Kudo, Takashi Kumada, Chiba Y
Background In SILIUS (NCT01214343), combination of sorafenib and hepatic arterial infusion chemotherapy did not significantly improve overall survival in patients with advanced hepatocellular carcinoma (HCC) compared with sorafenib alone. In this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6390136c5a26e190785fd7a79c9a9050
https://doi.org/10.20944/preprints201907.0075.v1
https://doi.org/10.20944/preprints201907.0075.v1
Autor:
Masatoshi Kudo, Kazuomi Ueshima, Osamu Yokosuka, Sadahisa Ogasawara, Shuntaro Obi, Namiki Izumi, Hiroshi Aikata, Hiroaki Nagano, Etsuro Hatano, Yutaka Sasaki, Keisuke Hino, Takashi Kumada, Kazuhide Yamamoto, Yasuharu Imai, Shouta Iwadou, Chikara Ogawa, Takuji Okusaka, Fumihiko Kanai, Kohei Akazawa, Ken-ichi Yoshimura, Philip Johnson, Yasuaki Arai
Publikováno v:
LANCET GASTROENTEROLOGY & HEPATOLOGY
Summary Background Hepatic arterial infusion chemotherapy plus sorafenib in phase 2 trials has shown favourable tumour control and a manageable safety profile in patients with advanced, unresectable hepatocellular carcinoma. However, no randomised ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e86201922a19102a95369359d427bf